1,329
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Association of a low ankle brachial index with progression to end-stage kidney disease in patients with advanced-stage diabetic kidney disease

, , , , &
Article: 2160347 | Received 18 Aug 2022, Accepted 12 Dec 2022, Published online: 12 Jan 2023

References

  • Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281.
  • Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care. 2004;27(Suppl 1): s79–83.
  • Afkarian M, Sachs MC, Kestenbaum B, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302–308.
  • American Diabetes A. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37:S14–S80. Suppl 1:
  • American Diabetes A. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–3341.
  • Cardoso CRL, Melo JV, Salles GC, et al. Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio De Janeiro type 2 diabetes cohort study. Diabetologia. 2018;61(11):2266–2276.
  • Moyer VA, Force U, U.S. Preventive Services Task Force Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: u.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159(5):342–348.
  • Guirguis-Blake JM, Evans CV, Redmond N, et al. Screening for peripheral artery disease using the Ankle-Brachial index: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(2):184–196.
  • Jin X, Ma JH, Shen Y, et al. An analysis of the relationship between ankle-brachial index and estimated glomerular filtration rate in type 2 diabetes. Angiology. 2013;64(3):237–241.
  • Dorans KS, He H, Chen J, CRIC Study Investigators, et al. Change in ankle-brachial index and mortality among individuals with chronic kidney disease: findings from the chronic renal insufficiency cohort study. Nephrol Dial Transplant. 2021;36(12):2224–2231.
  • Chang LH, Chu CH, Lin HD, et al. The ankle brachial index is associated with prognosis in patients with diabetic kidney disease. Diabetes Res Clin Pract. 2015;108(2):316–322.
  • Naito H, Hosomi N, Kuzume D, et al. Increased blood pressure variability during the subacute phase in patients with ischemic stroke presenting with a low ankle-brachial index. Geriatr Gerontol Int. 2020;20(5):448–454.
  • Kamath TP, Prasad R, Allison MA, et al. Association of Ankle-Brachial and Toe-Brachial indexes with mortality in patients with CKD. Kidney Med. 2020;2(1):68–75.
  • Sonoda H, Nakamura K, Tamakoshi A. Ankle-Brachial index is a predictor of future incident chronic kidney disease in a general japanese population. J Atheroscler Thromb. 2019;26(12):1054–1061.
  • Dong X, Wu D, Jia C, et al. Low ankle-brachial index is associated with early-stage chronic kidney disease in type 2 diabetic patients independent of albuminuria. PLoS One. 2014;9(10):e109641.
  • Sheen YJ, Lin JL, Lee IT, et al. Low estimated glomerular filtration rate is a major determinant of low ankle-brachial index and toe-brachial index in type 2 diabetes. Angiology. 2012;63(1):55–61.
  • Criqui MH, McClelland RL, McDermott MM, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506–1512.
  • Gerhard-Herman MD, Gornik HL, Barrett C, et al. AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. 2016;135(12):e726–e779. 2017
  • Schwandt A, Denkinger M, Fasching P, et al. Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes. J Diabetes Complications. 2017;31(9):1376–1383.
  • Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline. Ann Intern Med. 2021;174(3):385–394.
  • Rigalleau V, Cougnard-Gregoire A, Nov S, et al. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes. J Diabetes Complications. 2015;29(2):270–274.
  • Piko N, Bevc S, Ekart R, et al. Diabetic patients with chronic kidney disease: non-invasive assessment of cardiovascular risk. World J Diabetes. 2021;12(7):975–996.
  • Ishii H, Takahashi H, Ito Y, et al. The association of ankle brachial index, Protein-Energy wasting, and inflammation status with cardiovascular mortality in patients on chronic hemodialysis. Nutrients. 2017;9(4):416.
  • Ix JH, Katz R, De Boer IH, et al. Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (cardiovascular health study). J Am Coll Cardiol. 2009;54(13):1176–1184.
  • Chen SC, Chang JM, Liu WC, et al. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(4):724–732.
  • Subramanian N, Xu J, Sayyed Kassem L, et al. Absent or diminished pedal pulses and estimated GFR decline in patients with diabetic kidney disease. Ren Fail. 2019;41(1):691–697.
  • Griffin KA, Picken MM, Churchill M, et al. Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol. 2000;11(3):497–506.
  • Bidani AK, Griffin KA, Picken M, et al. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol. 1993;265(3 Pt 2):F391–398.
  • Arroyo D, Betriu A, Valls J, Investigators from the NEFRONA study, et al. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study. Nephrol Dial Transplant. 2017;32(3):513–520.
  • Brennan E, Kantharidis P, Cooper ME, et al. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725–739.
  • Dwyer KM, Kishore BK, Robson SC. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat Rev Nephrol. 2020;16(9):509–524.
  • Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899–1911.
  • Sueta D, Hokimoto S, Sakamoto K, Multi-center Study of Hemodialysis Patients Undergoing Invasive Cardiovascular Procedures Study Investigators, et al. Validation of the high mortality rate of Malnutrition-Inflammation-Atherosclerosis syndrome: -Community-based observational study. Int J Cardiol. 2017;230:97–102.
  • Lewis EJ, Hunsicker LG, Clarke WR, Collaborative Study Group, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–860.